Document is current

Any future updates will be listed below

B-Zell-Depletion 2.0: Bei NMOSD ist Anti-CD19-Immuntherapie wirksam

Crossref DOI link: https://doi.org/10.1007/s15005-020-1303-8

Published Online: 2020-04-27

Published Print: 2020-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark